Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SARS and Avian Flu -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (1209)	1/15/2004 6:29:43 PM
From: Henry Niman	Respond to of 4232

The was a bit more detail in the WSJ, but studies that take 90 patients to see which HLA haploypes jump out at the two ends of the curve really need to be tested in a new set of patients. There are many haplotpes and one is always go to be the best for susceptibility and another for resistance.

To: Biomaven who wrote (1209)	1/15/2004 6:31:18 PM
From: Henry Niman	Respond to of 4232

I did an update on the new SARS mutations based on media reports discuss.agonist.org There seem to be data for SARS CoV cousins and well as humanization.

To: Biomaven who wrote (1209)	1/16/2004 5:50:19 AM
From: Henry Niman	Respond to of 4232

Speaking of genes, I have put together a short review, SARS Sequence Secrets, of the civet sequences that strongly implicated them in the transmission chain and raised some issues about WHO's reluctance to go after the real source of the problem, the asymptomatic HUMANS infected with the virus discuss.agonist.org